לקסיבה

Ülke: İsrail

Dil: İbranice

Kaynak: Ministry of Health

Aktif bileşen:

FOSAMPRENAVIR AS FOSAMPRENAVIR CALCIUM 700 MG

Mevcut itibaren:

GLAXO SMITH KLINE (ISRAEL) LTD

ATC kodu:

J05AE07

Farmasötik formu:

TABLETS

Uygulama yolu:

PER OS

Tarafından üretildi:

GLAXO WELLCOME SA, SPAIN

Terapötik grubu:

FOSAMPRENAVIR

Terapötik endikasyonlar:

Lexiva is indicated in combination with other antiretroviral agents for the treatment of Human Immunodeficiency Virus (HIV) infection in adults. The following points should be considered when initiating therapy with Lexiva/ritonavir in protease inhibitor - experienced patients: - The protease inhibitor - experienced patient study was not large enough to reach a definitive conclusion that Lexiva/ritonavir and lopinavir/ritonavir are clinically equivalent. - Once - daily administration of Lexiva plus ritonvir is not recommended for proteaseinhibitor-experienced patients.

Yetkilendirme tarihi:

2012-01-01